On August 16, the FTC announced a settlement with Brain-Pad, Inc. which prohibits the company and its president, Joseph Manzo, from misrepresenting the health benefits of any mouthguard or other athletic equipment intended to protect against brain injuries.

According to the FTC’s press release, Brain-Pad and Manzo made unsubstantiated claims about the company’s mouthguards such as “creates new brain safety space,” “reduces risk of concussions from lower jaw impacts” and “reduces risk of concussions” in internet and print advertisements. In addition, the company’s advertisements claimed that the mounthguards’ ability to reduce the risk of concussion was “clinically proven.”

“Mouthguards can help to shield a person’s teeth from being injured, and some can reduce impact to the lower jaw,” said David Vladeck, Director of the FTC’s Bureau of Consumer Protection in the press release. “But it’s a big leap to say these devices can also reduce the risk of concussions. The scientific evidence to make that claim just isn’t adequate.”

The FTC cited the case as one of the Commission’s many recent investigations and settlements intended to combat overhyped health and fitness claims.

Click here to read the FTC’s press release and access a copy of the settlement agreement.